Literature DB >> 25532529

Spatial and time-course thermodynamics during pulmonary vein isolation using the second-generation cryoballoon in a canine in vivo model.

Mitsuru Takami1, Juna Misiri1, H Immo Lehmann1, Kay D Parker1, Susan B Johnson1, Ray I Sarmiento1, Douglas L Packer2.   

Abstract

BACKGROUND: Thermodynamics in the left atrium-pulmonary vein (PV) junction, phrenic nerve, and esophagus during PV isolation (PVI) using the second-generation cryoballoon are not known. METHODS AND
RESULTS: Twenty dogs underwent PVI using second-generation cryoballoon. Ablations were performed for ≤2 deliveries based on PVI without a bonus freeze. Inner balloon, balloon surface, and tissue temperatures were monitored during cryoablation. The tissue thermocouples were placed on the epicardial surface of the left atrium-PV junction, as well as on the phrenic nerve and within the esophagus. A total of 259 cryoballoon and 229 tissue tissue thermocouples profiles during 53 cryoablations of 40 PVs were analyzed. Acutely, PVI was achieved in 36 of 40 PVs (90%). Conductive tissue cooling spread radially from the balloon-left atrium-PV contact point. The lowest tissue temperatures were dependent on the distance of the tissue thermocouples to the balloon surface (r=0.85; P<0.001). In addition, blood flow leaks around the balloon had a warming effect on the balloon and tissue temperature profiles. Chronic isolation (mean, 48±16 days) was achieved in 27 of 36 PVs (75%). In 8 of 9 acutely isolated but with chronic reconnection PVs, the blood flow leak location was concordant with chronic reconnection gap. Although only 1 esophageal ulcerated lesion was observed, neither phrenic nerve palsy nor severe PV stenosis was seen in any dogs.
CONCLUSIONS: Variance in tissue thermodynamics during cryothermal ablation depends on the distance from balloon and peri-balloon blood flow leaks. This information may be useful for successful PVI without severe complications.
© 2014 American Heart Association, Inc.

Entities:  

Keywords:  atrial fibrillation; cryoballoon; pulmonary vein isolation; thermodynamics

Mesh:

Year:  2014        PMID: 25532529     DOI: 10.1161/CIRCEP.114.002137

Source DB:  PubMed          Journal:  Circ Arrhythm Electrophysiol        ISSN: 1941-3084


  6 in total

Review 1.  The Hot and the Cold: Radiofrequency Versus Cryoballoon Ablation for Atrial Fibrillation.

Authors:  Richard Ang; Giulia Domenichini; Malcolm C Finlay; Richard J Schilling; Ross J Hunter
Journal:  Curr Cardiol Rep       Date:  2015-09       Impact factor: 2.931

Review 2.  Outcomes Of Cryoballoon Ablation Of Atrial Fibrillation: A Comprehensive Review.

Authors:  Arash Aryana; Mark R Bowers; Padraig Gearoid O'Neill
Journal:  J Atr Fibrillation       Date:  2015-08-31

3.  Considering the Cryoballoon as a Multifaceted Tool for Extensive Left Atrial Ablation in Patients with Longstanding Persistent Atrial Fibrillation.

Authors: 
Journal:  J Innov Card Rhythm Manag       Date:  2022-01-15

4.  Left atrial posterior wall isolation in conjunction with pulmonary vein isolation using cryoballoon for treatment of persistent atrial fibrillation (PIVoTAL): study rationale and design.

Authors:  Arash Aryana; Deep K Pujara; Shelley L Allen; James H Baker; Martin A Espinosa; Eric F Buch; Uma Srivatsa; Ethan Ellis; Kevin Makati; Marcin Kowalski; Sung Lee; Thomas Tadros; Tina Baykaner; Amin Al-Ahmad; André d'Avila; Luigi Di Biase; Kaoru Okishige; Andrea Natale
Journal:  J Interv Card Electrophysiol       Date:  2020-10-03       Impact factor: 1.900

5.  Relationship between time-to-isolation and freeze duration: Computational modeling of dosing for Arctic Front Advance and Arctic Front Advance Pro cryoballoons.

Authors:  Michael K Getman; Erik Wissner; Ravi Ranjan; Jean-Pierre Lalonde
Journal:  J Cardiovasc Electrophysiol       Date:  2019-09-17

6.  Supplemental Radiofrequency Ablation After Acutely Unsuccessful Cryoballoon Pulmonary Vein Isolation is Associated With Increased Risk of Recurrent Atrial Fibrillation.

Authors:  Henry D Huang; Grzegorz Pietrasik; Qurrat-Ul-Ain Abid; Parikshit S Sharma; Kousik Krishnan; Timothy R Larsen; Richard G Trohman
Journal:  J Am Heart Assoc       Date:  2020-05-12       Impact factor: 5.501

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.